Parkinsonism in a patient with antiphospholipid syndrome - Case report and literature review

Journal of the Neurological Sciences

Volumn 267, Issue 1-2, 2008, Pages 166-169

  Huang, Yen Chu ^a   Lyu, Rong Kuo ^a   Chen, Sien Tsong ^a   Chu, Yi Chuan ^a   Wu, Yih Ru ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Antiphospholipid syndrome; Parkinsonism; Stroke; Thromboembolism

Indexed keywords

[2 [[2 [[[3 (4 CHLOROPHENYL) 8 METHYL 8 AZABICYCLO[3.2.1]OCT 2 YL]METHYL](2 MERCAPTOETHYL)AMINO]ETHYL]AMINO]ETHANETHIOLATO]OXOTECHNETIUM TC 99M; LEVODOPA; WARFARIN;

ADULT; ANAMNESIS; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CASE REPORT; CLINICAL FEATURE; FAMILY HISTORY; FEMALE; HUMAN; LABORATORY TEST; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; PARKINSONISM; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; ANTICOAGULANTS; ANTIPARKINSON AGENTS; ANTIPHOSPHOLIPID SYNDROME; BRAIN; CEREBRAL ARTERIES; CORPUS STRIATUM; DEMENTIA, VASCULAR; FEMALE; HUMANS; INTRACRANIAL THROMBOSIS; LEVODOPA; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSONIAN DISORDERS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME; WARFARIN;

EID: 39049155218     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2007.10.003     Document Type: Article

References (10)

1. Miyakis S., Lockshin M.D., Atsumi T., Branch D.W., Brey R.L., Cervera R., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4 (2006) 295-306
2. Sanna G., Bertolaccini M.L., Cuadrado M.J., Khamashta M.A., and Hughes G.R. Central nervous system involvement in the antiphospholipid (Hughes) syndrome. Rheumatol (Oxf) 42 (2003) 200-213
3. Martino D., Chew N.K., Mir P., Edwards M.J., Quinn N.P., and Bhatia K.P. Atypical movement disorders in antiphospholipid syndrome. Mov Disord 21 (2006) 944-949
4. Milanov I.G., Rashkov R., Baleva M., and Georgiev D. Antiphospholipid syndrome and parkinsonism. Clin Exp Rheumatol 16 (1998) 623-624
5. Milanov I., and Bogdanova D. Antiphospholipid syndrome and dystonia-parkinsonism. A case report. Parkinsonism Relat Disord 7 (2001) 139-141
6. Reitblat T., Polishchuk I., Dorodnikov E., Aladjem Z., Turiansky L., Zamir D., et al. Primary antiphospholipid antibody syndrome masquerading as progressive supranuclear palsy. Lupus 12 (2003) 67-69
7. Morris H.R., and Lees A.J. Primary antiphospholipid syndrome presenting as a corticobasal degeneration syndrome. Mov Disord 14 (1999) 530-532
8. Tzen K.Y., Lu C.S., Yen T.C., Wey S.P., and Ting G. Differential diagnosis of Parkinson's disease and vascular parkinsonism by (99 m)Tc-TRODAT-1. J Nucl Med 42 (2001) 408-413
9. Crowther M.A., Ginsberg J.S., Julian J., Denburg J., Hirsh J., Douketis J., et al. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. N Engl J Med 349 (2003) 1133-1138
10. Finazzi G., Marchioli R., Brancaccio V., Schinco P., Wisloff F., Musial J., et al. A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS). J Thromb Haemost 3 (2005) 848-853